Inteliview
Log inSign up
US StocksPOSITIVE

Up 42% in Two Days, 70% YTD — Why Rocket Lab Became the SpaceX IPO Proxy

Rocket Lab (RKLB) surged 42% over two days after Q1 earnings, now up 70% YTD. A 108% backlog surge and Golden Dome defense contract drove the fundamental case. SpaceX's imminent June IPO is funneling space-sector capital into the most credible listed proxy.

Justin Jeon··Updated May 12, 2026 at 09:36·6 min read
Also available in Korean한국어로 보기 →
rocket-lab-rklb-spacex-ipo-proxy-golden-dome-q1-2026
rocket-lab-rklb-spacex-ipo-proxy-golden-dome-q1-2026
AIKey Summary
  • Rocket Lab (RKLB) surged 42% in two days after Q1 earnings, now 70% YTD
  • Revenue +63.5%, backlog +108% YoY, and Golden Dome defense selection form the fundamental case; SpaceX's June 2026 IPO is driving proxy capital into RKLB

Rocket Lab (RKLB) is surging for a second consecutive day. After a 30% explosion on the day following its Q1 earnings report on May 7th, shares added another 12% intraday on Monday May 11th, setting a new all-time high. Up 70% year-to-date. The fundamentals were solid. But something beyond the earnings is driving this two-day rally.


The Numbers First — Backlog Up 108%

  • Q1 revenue $203M, up 63.5% YoY. First quarter ever above $200M.
  • EPS -$0.07, beating consensus of -$0.08
  • Q2 guidance midpoint $232.5M — 12% above analyst consensus
  • Backlog $2.2B — up +20% QoQ, up +108% YoY, new all-time high

CEO Peter Beck disclosed that Rocket Lab signed 31 Electron and HASTE launch contracts in Q1 alone — a single-quarter record. Five new Neutron-dedicated launch contracts were also signed.

A $2.2B backlog represents roughly 2.7× current annual revenue in pre-booked orders. Investors read that as 2–3 years of revenue visibility locked in.


Golden Dome Contract — Defense Narrative Added

A strategic contract alongside the earnings added a stronger signal. Rocket Lab was selected alongside Raytheon (RTX) for the U.S. Department of Defense's Space Based Interceptor program. It will provide launch services and satellite technology supporting President Trump's Golden Dome missile defense initiative.

A commercial space company winning a core national security space contract is a milestone. The defense narrative now sits on top of the commercial space story. Contract value was not disclosed.

The company also announced the acquisition of Motiv Space Systems, a space robotics firm with NASA Mars rover technology — part of Rocket Lab's push from launch services into full space systems.


SpaceX IPO Proxy — The Real Catalyst

Strong earnings and contracts alone don't explain two consecutive days of this magnitude. SpaceX's IPO does.

Reports surfaced that SpaceX is targeting an IPO as early as June 2026, filing a confidential registration at a $2 trillion valuation. SpaceX is private. Retail investors have no direct access. But capital that wants exposure to the space sector has to go somewhere.

Rocket Lab is the most credible publicly traded pure-play launch company. As SpaceX's IPO materializes, capital flows into the space sector broadly — and concentrates in the listed proxy.

Market structure observation

This pattern has repeated historically. When a major private company's IPO becomes imminent, listed comparables move first. That dynamic is playing out in RKLB now.


SpaceX vs Rocket Lab: Competitors or Complements?

More complementary than competitive at present. SpaceX dominates large-payload, reusable, high-volume launches with Falcon 9 and Starship. Rocket Lab specializes in small satellite dedicated launches with Electron. When Neutron completes, overlap in the medium class will grow — but today it's largely additive.

From an investor lens, Rocket Lab is "the company capturing share where SpaceX doesn't focus." And if a SpaceX IPO re-rates the entire space sector's valuation framework, RKLB benefits from the same rising tide.


One Risk to Watch

Proxy premium is a double-edged sword. Once SpaceX actually lists, investors can buy SpaceX directly. The "listed proxy" premium could compress at that point. Near-term: IPO anticipation tailwind. Longer-term: watch for SpaceX listing + premium erosion risk.

Loading...

Frequently Asked Questions

Is SpaceX's IPO a positive or negative for Rocket Lab?

Near-term positive. IPO anticipation drives capital into the broader space sector, and Rocket Lab is the most credible listed proxy. Longer-term, once SpaceX lists, investors can buy SpaceX directly — which could compress the proxy premium currently embedded in RKLB's valuation. The timeline of that transition is the key risk to manage.

What does a $2.2B backlog mean for Rocket Lab?

It represents roughly 2.7× current annual revenue in pre-booked orders. Investors read it as 2–3 years of revenue visibility locked in. A 108% YoY jump signals that demand acceleration is ongoing, not decelerating.

What exactly did Rocket Lab win from the Golden Dome program?

Rocket Lab was selected alongside Raytheon (RTX) for the Department of Defense's Space Based Interceptor program, providing launch services and satellite technology for Trump's Golden Dome missile defense initiative. The exact contract value was not disclosed. It marks a commercial space company becoming a core partner in a national security space program.

When is the Neutron rocket expected to launch?

Rocket Lab signed five Neutron-dedicated launch contracts in Q1, but no specific first-launch date has been disclosed. Once operational, Neutron's medium-lift capability significantly expands Rocket Lab's TAM and creates some overlap with SpaceX's Falcon 9 in the medium-payload segment.

Justin Jeon
Author

Justin Jeon

Topics
FREE MEMBERSHIP

Did you find this useful?

Sign up to bookmark articles, follow gurus, and manage your portfolio — all for free.

Guru trade alerts
Portfolio tracker
Article bookmarks

Related Articles

Wall Street's Defining Moments

See more
Browse defining moments

Insights

INTELIVIEW NEWSLETTER

Smart Money Briefing

Weekly summaries of Wall Street guru moves and crypto whale activity.